"But when she got there, the cupboard was bare."
Post# of 153815
(Total Views: 708)
Posted On: 07/06/2020 1:51:30 PM
"But when she got there, the cupboard was bare."
In the interview with Dr. Been, Pourhassan dodged the question of supply of Leronlimab.
Dr. Been correctly observed that Cytodyn was going to need billions and billions of doses in the near future for all the indications it can treat. Each treatment for whatever is going to take multiple doses.
I maintain that there is probably no possibility of approval for Leronlimab for much of anything until there is something in the cupboard, literally. There is no rush to end the trials early no matter how well things are going until more product is in hand.
This is not Pourhassen's fault. Where is all the Operation Warp Speed help, the CTAP help, the BARTA help? I do so hope Pourhassen knows more that what he is saying but I don't know why he would not tell us about expidited supply provisions. Would it indicate that approval of Leronlimab is all but a done deal? Massive supply is on the way? But Pourhassen only, again, mentioned the 1.2 million shares due BY THE END OF THE YEAR! 300,000 treatments worth!
There's a huge disconnect here. What's the answer?
In the interview with Dr. Been, Pourhassan dodged the question of supply of Leronlimab.
Dr. Been correctly observed that Cytodyn was going to need billions and billions of doses in the near future for all the indications it can treat. Each treatment for whatever is going to take multiple doses.
I maintain that there is probably no possibility of approval for Leronlimab for much of anything until there is something in the cupboard, literally. There is no rush to end the trials early no matter how well things are going until more product is in hand.
This is not Pourhassen's fault. Where is all the Operation Warp Speed help, the CTAP help, the BARTA help? I do so hope Pourhassen knows more that what he is saying but I don't know why he would not tell us about expidited supply provisions. Would it indicate that approval of Leronlimab is all but a done deal? Massive supply is on the way? But Pourhassen only, again, mentioned the 1.2 million shares due BY THE END OF THE YEAR! 300,000 treatments worth!
There's a huge disconnect here. What's the answer?
(0)
(0)